It has been for many decades a dogma in immunology that only substances of relatively high molecular weight are able to function as complete immunogens and to induce the formation of antibodies and/or delayed hypersensitivity (1). Compounds of low molecular weight and simple sensitizing chemicals (2) have been considered haptens, only able to become immunogenic when covalenfly bound to some large molecular weight protein carrier. For quite a while the size limit ascribed to immunogenic molecules was 10,000 (3). However, more recent studies on the immunogenicity of oligopeptides have indicated that compounds with a molecular weight as low as 4000 may also be immunogenlc (4). Furthermore, reports from several groups of workers have indicated that even smaller molecules, i.e. hapten-amino acids or hapten-oligopeptides, may behave as immtmogens. The first published report on the immunogenicity of hapten-amino acids appears to be that of Jansen, Berrens, and van Delden (5), who described the induction of contact dermatitis to dinitrochlorobenzene in pigs by injection of a mixture of diultrophenyl amino acids. We observed independently a similar phenomenon in guinea pigs and reported some preliminary data in 1966 (6). Furthermore, the immunogenicity of hapten-amino acids has been reported with the p-azobenzenearsonate hapten by Leskowitz and his collaborators (7) and by Borek and coworkers (8). However, before accepting at face value the contention that haptenamino acids are effective immunogens, previous negative results (9) should also be remembered.
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The finding that some hapten-amino acid compounds do induce contact sensitization and the formation of anti-hapten antibodies is of both theoretical and practical interest. The possibility that simple hapten-amino acid conjugates may behave as immunogens would open new perspectives in the understanding of contact sensitization and drug allergy in man. Furthermore, hapten-amino acids might prove to be very suitable substances for studying the biochemical pathways responsible for the induction of the immune response.
The purpose of this investigation was to establish in a quantitative and controlled manner a catalogue of DNP-amino acids 1 capable of inducing an immune arations tested were subjected to thin layer chromatography in the dark on silica gel plates. Thin layer plates were developed for all DNP preparations in at least three solvent systems, but in most instances six to eight solvent systems were used. These solvent systems permitted the separation of the DNP-amino acid to be examined from the internal standards used (DNFB, DNOH, DNPNIt~). The chromatograms were examined under daylight and ultraviolet light. For staining we used the chiorobenzidine method of Reindel and Hoppe (12) , and for nitro groups, a reagent consistingof dimethylaminobenzaldehyde and stannous chloride (13) . As controls for possible impurities, DNOH, DNPNI-I2, and DNFB were added in various amounts (0.1-1/~g) to the compound being examined. The sensitivity limit for these substances, under the experimental conditions used, was 0.05-0.1/zg. Thin layer chromatography was also used to detect possible sodium fluoride impurities, which after staining with the aiizarin-zirconlum reagent (14) could unequivocally be demonstrated in amounts as low as 5 #g.
The possible presence of fluorinated impurities and/or inorganic fluorine was also investigated by microanalytical techniques (15, 16) . The titration procedure used had a sensitivity limit of 0.06%.
Ash of the DNP-amino acid preparations was also examined qualitatively for the presence of fluorine with the alizarin-fluorine blue-lanthanum complex reaction according to Belcher (17) .
A nimals.--White spotted Himalayan guinea pigs of either sex, weighing 300-500 g and originating from a closed colony, were used throughout. They were fed on a pellet diet, with additional greens and water ad libitum. Rabbits were from a mixed random stock, weighed 3-3.5 kg at the start of immunization, and were fed a standard pellet diet.
Immunization Procedures.--DNP-amino adds were used whenever possible as 1% solutions in water. The less soluble compounds were dissolved in 1-4% sodium bicarbonate by heating in a water bath at 50°C. The standard immunization procedure in guinea pigs consisted in five intradermal injections of 0.1 ml in the flank adminl.qtered on days 0, 2, 4, 7, and 9 (total dose, 5 rag) without adjuvant. Dose-responso curves were established with correspondingly reduced doses.
DNCB and DNFB were dissolved in an alcohol-saline mixture, and 0.1 ml cont~inlng 0.025-100/~g was injected intradermally on days 0, 2, 4, 7, and 9.
DNOH and DNPNH~ were dissolved in water, and 0.1 ml cont~inlng 1.25-10/~g was injected intradermally according to the same schedule.
Eplcu~aneou~ sensitizoJion to DNCB: 0.002 ml of a 50% solution in acetone containing 1 mg DNCB was applied with a pipette to the shaved skin of the guinea pigs' necks. The site was then covered with adhesive tape, which was left in place for 7 days.
Rabbits were injected subcutaneously in the footpads with DNP-amino acids in complete Frennd's adjuvant (Difco Laboratories, Detroit, Mich.) in doses of 13-20 rag. Several subcutaneous booster injections without adjuvant were administered after 3 and 7 wk.
Skin Test Procedures.--
Intradermal tests tv~k DNP-amino acids: 0.1 nil of a 1% solution in water orin 1-4% sodium bicarbonate (similar to the sensitizing injections) was injected intradermally on the 21st postimmunization day, the reactions being read after 6, 18, 24, and 48 hr. A reaction was considered positive only when the diameter of the lesion exceeded by 50% or more the average primary toxic reaction elicited in normal controls. When DNP-amino acids with particularly high primalt skin toxicity were tested, lower test concentrations, such as 0.5, 0.3, or 0.1% were used.
Epicutaneous tests wltk DNCB: 0.025 ml solutions of DNCB in acetone at 0.09, 0.05, and 0.03% were applied with a pipette to three skin areas of 2 cm 2 each. Such concentrations are nontoxic for normal guinea pigs. The contact reactions were evaluated after 24 hr according to an arbitrary scale from 0 to 3, described previously (11) . The average degree of contact sensitivity is given by the arithmetic mean of all reactions of an animal group.
Detection and Ckaracteriza~ion of Anti-dinitropkenyl Antibodies.--Guinea pigs were bled by cardiac puncture 14 days after the first injection of DNP-amino acid, i.e. before any testing, and again on day 22, i.e. 1 day after the epicutaneous and intradermal tests. Anti-dinitrophenyl antibodies were determined by immunodiffusion and by passive cutaneous anaphylaxis. Immunodiffnsion was performed on microslides or in agar Petri dishes according to Pepys et al. (18) , using DNP17-HSA as antigen at the standard concentration of 5 mg/mL For PCA, sera were diluted 1:5 in 0.01 ~ phosphate-saline, and 0.1 ml was injected intradermally in two or three normal guinea pigs. The intravenous challenge was performed after 20-24 hr with 0.5 ml of DNPI~-HSA containing approximately 2 mg of conjugate and 0.5 ml 2% Evans blue. The diameter of blueing reactions was recorded after 20-30 rain.
Rabbits were bled on the 14th post-immunization day and repeatedly after different series of booster injections up to the 70th day. Antibodies were looked for by immunodiffusion, PCA, and direct precipitation in solution. Immunodiffusion was performed in agar Petri di.~hes (18) and on microslides with DNP17-HSA as antigen at concentrations varying between 0.1 and 3 mg/ml. Precipitation and specific inhibition curves established with DNP17-HSA as antigen were determined spectrophotometrically according to the technique of Eisen (19) . PCA studies with rabbit sera were performed as described above.
Systemic Anaphylaods.--Guinea pigs were injected intravenously with 0.5 ml/kg of DNPla-BGG on day 22, i.e. 1 day after the epicutancous and intmdermal tests.
RESULTS

Immunogenicity of DNP-Amlno Acids and DNP Derivatives in Guinea
Pigs; Screening Results.--All compounds studied are listed in Table I . A preparation was considered to be immunogenic when it induced either immediate or delayed type hypersensitivity. Among 35 DNP-amino acids and DNP derivatives studied, 17 induced both immediate and delayed hypersensitivity; 8 only delayed hypersensitivity; and 10 were not immunogenic.
Most compounds were studied repeatedly on groups of four to eight guinea pigs. Results obtained several months apart were always concordant and reproducible, whether the compounds were immunogenic or nonimmunogenic.
On the other hand, four DNP-amino acids (Nos. 2, 4, 5, and 10) tested under similar conditions gave discordant results when different lots of the same preparation, produced by different manufacturers, were tested. The possible causes of such differences will be discussed below.
Induction of Delayed ttypersensitivity.--
Intradermal tests with DNP-amino acids were performed on the 21st postimmunization day. Positive reactions consisted of red, indurated papules appearing after 6 hr and reaching a diameter of 15-20 mm after 24 hr, surrounded by an erythematons and edematous zone measuring 25-30 ram. Strong reactions often presented central necrosis. After 48 hr the surrounding edematous zone disappeared, the necrotic papule persisting for 3-5 days. The induction of this type of response became visible during the sensitizing course; the first, second, and third injections caused only weak primary toxic lesions, while the fourth and fifth injections provoked strong reactions resembling the test performed on the 21st day.
Contact reactions to DNCB: Sensitized animals showed strongly positive reactions when tested on the 21st day, i.e. at their first contact with DNCB. Anaphylactic shock was observed in animals immunized with 8 out of 25 DN-P-amino acid preparations, when challenged intravenously with DNP-BGG on day 22, i.e. 1 day after the tests. In no case was anaphylactic shock elicited with any DNP-amino acid (100 mg/kg intravenously) in animals immunized with the corresponding DNP-amino acid or with DNCB.
Induction of Anti
Cross-reactivity belween DNP-Amino Acids and DNCB.--In the first series of experiments, groups of guinea pigs immunized with a DNP-amino acid were tested, as a rule, with DNCB and with DNP-amino acids other than the one used for immunization. Sensitized animals cross-reacted with many other immunogenic DNP-amino acids and always with DNCB, but not with nonimmunogenic DNP-axnino acids (with two exceptions, Nos. 21 and 24). In all, 25 DNP-amino acids were investigated in this way.
In another series of experiments, the guinea pigs were sensitized with DNCB and then tested with immunogenic and nonimmunogenic DNP-amino acids. Such animals cross-reacted with 11 out of the 19 of the immunogenic DNPamino acids so tested, but in one case also with a nonimmunogenic compound.
Immunogenicity of DNP-Amino Acids in R.abbits.--In rabbits immunized with di-DNP-L-histidine (No. 15c), no anti-DNP antibodies were detected on day 14. On day 38, after a course of five booster injections, enough antibody was present to be detected by PCA and by immunodiffusion. The DNP derivatives of DL-glutamic acid (No. 10b) and S-L-cysteine (No. 8) showed somewhat weaker immunogenicity.
Quantitative Evaluation of the Immunogenicity of DNP-Amino Acids Compared to Other DNP Compounds Possibly Present as
Impurities.--To ascertain whether the immunogenicity of the DNP-amino acids studied might have been due to immunogenic impurities with DNP specificity, we evaluated quantitatively in vivo the immunogenicity of DNP-arnino acids in comparison with DNFB, DNOH, DNPNH~, and DNP-protein conjugates they could possibly contain. Fig. 1 shows that a dear dose-response relationship was obtained with di-DNP-l~-histidine (No. 15c) for both the sensitizing and the eliciting dose. Similar curves were obtained with mono-O-DNP-L-tyrosine and DNP-e-aminocaproic acid. Therefore delayed hyper-
Dose-response curves of some DNP-amino acids for inducing and eliciting delayed reactions to the sensitizer itself:
sensitivity to DNP-amino acids is induced by total doses of 50-250 #g, whereas the elicitafion of positive delayed reactions (50 % above controls) requires an intradermal dose of about 100 Izg. Dose-response curves of ~arious DNP-amino acids for eliciting delayed reactions in animals sensitized with DNCB ( Fig. 2 ): Such animals tested on day 21 showed a clear dose-response relationship for the eliciting doses of immunogenic DNPamino acids. Nonimmunogeuic amino acids, DNOH, and DNPNH~ showed reactions similar to those of the nonsensitized controls. Fig. 3 shows that di-DNP-L-hisfidine (No. 15a and c), as well as mono-O-DNP-L-tyrosine and DNP-¢-aminocaproic acid, regularly induced a dose-dependent contact sensitivity to DNCB (score, 1.0-2.0) with total doses varying between 50 and 250 #g. DNFB induced the same degree of contact sensitivity in doses of 1-2.5 #g, but no contact sensitivity was obtained with DNOH and DNPNI-I~ at doses of 10-50 #g. With DNBSOs, doses of 5000 t~g were necessary. DNP-protein conjugates did not induce contact sensitization to DNCB. Fig. 4 shows that di-DNP-L-histidine, mono-O-DNP-L-tyrosine, and DNP-e-amino caprolc acid in total doses of 500-2500 #g regularly produced anti-DNP antibodies demonstrable by PCA. To induce DNP antibodies yield- ing PCA reactions of similar intensity, doses of 25-50 #g DNFB and 25 #g DNP-BGG were necessary. No anti-DNP antibodies were produced by DNOH and DNPNH2 (total dose, 10-50 #g) or DNBSOs (total dose, 5000 #g). PCA results from the second bleeding on day 22 (after testing) were essentially similar.
Immunogenicity of DNP-amino acids compared to that of DNFB for inducing contact sensitivity to DNCB:
Immunogenicity of some DNP-amino acids for inducing anti-DNP antibodies compared to that of DNFB and DNP-protein conjugates and related DNP compounds:
To investigate whether "nonimmunogenid' DN-P-amino acids were inactive because the dose of 5 X Img used for screening was too low, the DNP deriva- Table I .
Contamination with DNFB: A number of preparations appeared to be relatively impure, containing DNFB in amounts varying between 0.2 % (Nos. 18 and 19), 0.05% (No. 4b), and less than 0.02% (No. 4a). In all other cases, DNFB was not found and was excluded at the level of 0.05%. However, from the comparative dose-response curves and in order to explain the immunogenicity of some DNP-amino acid preparations by contamination with DNFB, their DNFB content should be of the order of 1-5 %. Furthermore, recrystallization of di-DNP-L-histidine (No. 15c) up to 10 times did not impair its immunogenicity (Fig. 3) . We felt, therefore, that the immunogenicity of most of the DNP-amino acid preparations could not have been due to DNFB contamination (20) .
Contamination with DNOtt and DNPNH2: Several preparations contained DNOH (Nos. 1, 5a, 11, 12a, and 23), DNPNH, (No. 23), or unidentified impurities ( Nos. 1, 4a, 4b, 10b, 15a, 18, 19, 23, 27a, and 29b) . However, we found 27 chromatographically homogeneous preparations in which DNFB, DNOH, and DNPNH2 were not detected and could be excluded at the level of 0.05 %. Among these preparations, 18 were found to be immunogenic and 9 were not. Furthermore, when DNOH and DNPNH, were injected according to the usual immunization schedule at doses much higher than those possibly present as impurities in the DNP-amino acid preparations, no sensitization was achieved (Table I and Fig. 3 ). DNOH and DNPNH2 were also incapable of eliciting reactions in sensitized animals.
Contamination with fluorine: Some preparations contained traces of inorganic fluorine formed during the reaction between DNFB and amino acids. In other preparations, organic fluorine was found in the range of 0.19-0.9%. If ascribed to a DNFB impurity, such amounts would correspond to 2-9 % contamination with DNFB, which was ruled out by the chromatographic data. No relationship was observed between the content of organic fluorine and immunogenicity: some preparations with a high content of fluorine (Nos. 2a, 4a, and 29b) were not immunogenic, whereas others in which fluorine was not detected (Nos. 10a and 28) were nevertheless immunogenic.
Assuming that some molecules of DNFB could carry 2 fluorine atoms, a proportion of the reaction product with amino acids would be dinitrofluorophenylamino acids susceptible of further conjugation. However, examination of several samples of DNFB of different origins by mass spectrography did not disclose a second atom of fluorine in the DNFB molecule. Ultimate purification was achieved by countercurrent distribution of di-DNP-L-histidine (No. 15c).
This preparation, in which the presence of DNFB could he entirely excluded, ~ was nevertheless as immunogenic as before.
Photodecomposition and heat degradation products:
It is well known that DNP-amino acids axe sensitive to light (21) . The major photodecomposition reaction appears to be a decarboxylation yielding the corresponding N-alkyldinitroaniline, CO2, and volatile acidic compounds of unknown structure (22) . Other known degradation products are 4-nitro-2-nitrosoaniHne and a 2-substituted 6-nitrobenzimidazole 1-oxide (23) . The/$-, ~-, and ~-DNP groups are considered to be resistant to light, and DNP-peptides axe more stable than a-DNP-amino acids. In order to establish whether photodecomposition or the slight heating sometimes required for dissolution would influence immunogenicity, di-DNP-L-histidine and S-DNP-cysteine dissolved in 4% sodium bicarbonate were exposed to sunlight or to ordinary daylight for 30 min. Mere daylight did not provoke chromatographic changes. After exposure to sunlight, new additional spots were found, which did not correspond to DNOH, DNPNI-I2, or DNFB. Upon heating N,O-di-DNP-L-tyrosine in pyridine or 4% sodium bicarbonate at 50°C for 5 hr, no chromatographic changes were observed. Light and ultraviolet irradiation of di-DNP-L-histidine did not increase its immunogenicity. No sensitization was achieved with ultraviolet-irradiated solutions of the nonimmunogenic DNP-L-proline. Under our experimental conditions, therefore, in which the solutions were exposed to ordinary daylight for less than 30 rain, no major changes occurred.
DNP-protein contaminants:
Di-DNP-L-histidine (No. 15b) was analyzed for DNP-protein impurities. Ultracentrifugation of an aqueous extract showed that possible water-soluble impurities amounted to less than 0.02%. Di-DNP-Lhistidine dissolved in aqueous 1% bicarbonate solution tended to form miceUes, whereas it behaved as a single homogeneous substance in dimethylformamide. The same preparation (No. 15b), when subjected to column chromatography on Sephadex G-25, showed no front peak with ultraviolet absorption at 360 urn, and the presence of DNP-protein impurities could accordingly be excluded at the 0.01% level. These findings rule out the possibility that undetected DNPprotein impurities carried along during the manufacturing process could have been responsible for the immunogenic activity of di-DNP-L-histidine.
Countercurrent Distribution of Di-DNP-L-histidine (No. 15b
).--Di-DNP-L-histidine (4.0 g) was distributed between the phases of a system consisting of 0.1 ~ aqueous NaHCO3 (the pH adjusted to 7.6 with HC1) and toluene, 1:1, in a Craig distribution train operating with 10 ml of each phase per tube. After 100 transfers the di-DNP-L-histidine was distributed over the first 15 tubes. The impurities (0.95%), with a mean K (partition coefficient) of 0.1, were found by residual weight analysis in a broad peak from tubes 70 to 100. By taking K ~ 6.1 as a basis for calculation, less than 10--90% of the separated material was left with the purified di-DNP-L-histidine in the first 14 tubes. DNFB, which travels with K ~ 13, was not found under these conditions.
Possible influence of the solvent on immunogeni¢ity:
The fact that most DNPamino acids were dissolved in 2--4% sodium bicarbonate does not appear to play a role. The immunogenicity of di-DNP-L-histidine and O-DNP-L-tyrosine dissolved in 24% bicarbonate was compared with that of the same substances dissolved in dimethylformamide. Upon testing the animals with different doses ranging from 1000 to 10 pg, similar dose-response curves were obtained for each compound regardless of the solvent used for immunization.
Differences in the Immunogenicity of Various Lots of the Same DNP-Amino
Add.--With four DNP-amino acids, DNP-L-alanine (Nos. 2a and 2b), DNP-L-asparagine (Nos. 4a and 4b), DNP-L-aspartic acid (Nos. 5a and 5b), and DNP-DL-glutamic acid (No. 10ad), sensitization was achieved with a lot purchased from one manufacturer (Mann), whereas the same compound supplied by others (British Drug Houses and Sigma) was inactive (Tables I and ID. Cross-testing with different lots of the same substance showed that only immunogenic lots were able to elicit reactions. Table I. DNFB, DNOH, and DNTNHt <0.05%. § Not included in Table I . U DNFB <0.05%; one or two unidentified additional spots.
As each lot certainly contained the stated DNP-amino acid, the variable immunogenicity and eliciting capacity of different lots of the same compounds most probably was due to a highly immtmogenic impurity rather than to the DNP-amino acid itself. If the DNP-amino acid itself were immunogenlc, cross-reactions between various lots would be expected. Chromatographic and chemical analyses of these preparations were therefore of critical importance for the interpretation of the results. From the data presented in Table II , a conflicting picture emerges. In the case of DNP-DL-glutamic acid, the immunogenic lot from M~nn~ S 1107, certainly appeared somewhat impure (chromatographic heterogeneity, higher content in organic fluorine) in comparison with the nonimmunogenic lots from British Drug Houses and Sigma. However, strlk{ng differences in immunogenicity were observed between chromatographically identical preparations, and no relationship to the fluorine content could be established.
The differences in {mmunogenicity among various lots were verified not to be due to genetic differences among our guinea pigs. Guinea pigs injected with a nonlmmunogenic lot of DNP-L-alanine were subsequently sensitized without difficulty with an immunogenic lot of the same DNP-amino acid.
Potentiation of the Immunogenicity of DNFB by DNP-Amino Acids, Fluorides, or
Freund's Adjuvant--It often appeared impossible, on the basis of chromatographic data, that the immunogenicity of a given DNP-amino acid lot could have been due to contamination with unreacted DNFB. However, it could not be excluded a priori that some impurity or the nonimmunogenic DNP-arnino acid itself might potentiate the immunogenic effect of undetectable traces of DNFB (e.g. due to an unspecific inflammatory effect in the skin). Accordingly, we injected some animal groups intradermaUy with small amounts of DNFB (5 X 4/~g) mixed with increasing amounts (S X 10-1000/~g) of a nonimmunogenie DNP-amino acid such as DNP-L~valine. No potentiation effect was noticed. The addition of sodium fluoride or ammonium fluoride in doses of 5 X 1-1.25 mg to immunogenic and nonimmunogenic lots of DNP-DL-glutamic acid did not modify this immunogenicity.
The incorporation of DNFB or di-DNP-n-histidine in complete Freund's adjuvant (one single injection) had a marked effect upon the induction of delayed and contact hypersensitivity to DNCB: the immunogenicity threshold was lowered for DNFB to 1/zg, and for di-DNP-L-histidine to 10 ~g. On the other hand, incorporation in complete Freund's adjuvant did not lower the immunogenicity threshold as far as PCA-active anti-DNP antibodies were concerned.
Production of Immunogeniv DNP Conjugates upon Invubation of Di-DNP-Lhistidine with Bovine T-Globulin In Vitro.--As the immunogenicity of di-
DNP-L-histidine was not modified by repeated crystallization up to 10 times or by exclusion of DNFB impurities by countercurrent distribution, we decided to check whether di-DNP-L-histidine could perhaps form immunogenic conjugates with a carrier protein when incubated in vitro. Accordingly, 100 mg di-DNP-T.-histidine 10 times recrystallized were incubated with 100 mg BGG in 10 ml 0.01 phosphate-saline for 24 hr at 37°C in the dark. Mter incubation, the mixture was chromatographed on a Sephadex G-25 column, and the first peak containing the protein was collected. In a control experiment, di-DNP-L-histidine was incubated under the same conditions except that BGG was only added immediately prior to chromatographic separation. From spectrophotometric analysis and from the ratio of optical densities at 360 nm, it could not be ascertained whether conjugation had taken place in the incubated sample. The slight difference in As~o:A~ ratio observed amounted to less than 0.5 DNP group/molecule BGG in the incubated sample. However, when both protein samples were used to immunize guinea pigs, it became evident that BGG incubated for 24 hr with di-DNP-T.-histidine was able to induce the formation of DNP-specific antibodies whereas BGG merely mixed with di-DNP-L-histidine prior to chromatographic separation could only induce antibodies with BGG specificity. None of the protein samples could precipitate anti-DNP antibodies or elicit allergic reactions of DNP specificity in animals immunized with other DNP-proteins (e.g. DNP-HSA).
Specificity of Rabbit Precipitating Antibodies Induced by Di-DNP-L-histidine.
--As rabbits injected with di-DNP-L-histidine formed antibodies which could be precipitated by various DNP-protein conjugates (e.g. DNPlr-HSA), it became possible to assess the specificity of such antibodies by precipitation inhibition. DNP17-HSA precipitated about 150 #g antibody protein/ml in the best anti-di-DNP-L-histidine sera. A 7-globuiin fraction prepared by ammonium sulfate precipitation (24) was compared with one containing antibodies induced in rabbits by DNP-BGG. Antibody concentrations were adjusted to obtain approximately equal amounts of precipitate with DNPI~-HSA at equivalence, and various amounts of DNP-¢-aminocaproate or di-DNP-L-histidine were added for specific inhibition. The results are shown in Fig. 5 .
Since the DNP-BGG conjugate serving for immunization had been prepared with dinitrobenzenesulfonic acid (11), the antigenic determinants were almost exclusively of DNP-E-L-lysyl specificity. ¢-DNP-lysine and ¢-DNP-~mlno caproate appeared to be the best inhibitors for the precipitation of such antibodies. It is noteworthy that antibodies induced by di-DNP-L-histidine showed a very similar inhibition pattern, DNP-¢-aminocaproate being a better inhibitor than the immunizing DNP-amino acid itself.
DISCUSSION
The present investigation was undertaken in order to ascertain whether molecules as small as DNP-amino acids are able to function as immunogens. From an operational point of view, we found that numerous I)NP-amino acids can induce delayed and/or immediate type hypersensitivity of DNP specificity. Among 35 DNP-amino acids or DNP derivatives studied, 10 were found to be nonlmmunogenic, 15 were irregularly immunogenic (erratic sensitization and variations from one preparation lot to another), and 10 were always immunogenic, even despite extensive recrystaUization and purification.
Before being able to interpret these findings, we had to establish that the immune response was indeed induced by the DNP-amino acid molecule itself and not by some immunogenic impurity of DNP specificity carried along during the manufacturing and purification procedures.
The irregular immunogenicity of numerous DNP-amino acid preparations could theoretically be explained by the presence of small amounts of unreacted DNFB able to form DNP conjugates in vivo. This would be compatible with (a) the extensive cross-reactivity among immunogenic DNP-~mino acids and DNCB, (b) the requirement for relatively high doses of DNP-amino acids in comparison to DNFB, and (c) the fact that a few DNP-amino acids--nonimmunogeuic at the dose of 5 rag--became immunogenic when injected in higher amounts. On the other hand, chromatographic and microanalytical data are incompatible with the assumption that DNFB could be the impurity responsible for DNP-specific sensitization induced by several DNP-amino acid lots. In most instances, the dose-response curves obtained could only be explained by a 1-5 % DNFB impurity, which would certainly have been detected by chromatography. The immunogenicity of such chromatographically "pure" DNP-amino acids therefore has to be explained either by potentiation of ~mmunogenlc DNFB traces, by unknown factors, or by another undetected and highly immunogenic impurity with DNP specificity. The fact that immunogenic and nonimmunogenlc lots of the same DNP-amino acid could not be distinguished analytically leads us to conclude that criteria of purity usually accepted in analytical chemistry may be insufficient for the interpretation of immunochemicai data.
However, in the instances of DNP-amlno acids whose immunogenicity was constant from one preparation lot to another and was not impaired by repeated recrystallization and other purification procedures such as countercurrent distribution, it appears much more likely that the DNP-amino acid itself was responsible for sensitization. This is practically certain for di-DNP-L-histidine, which we studied most extensively. What is the fate of a DNP derivative such as di-DNP-L-histidine in vivo, and in what molecular form does it induce sensitization? Does the DNP-amino acid act as such on the immunocompetent cell, or only after binding in some way with an autologous protein? The theoretical possibility that a DNP-amino acid could be used in protein synthesis and incorporated into autologous proteins appears extremely unlikely.
On the other hand, we had to consider the possibility that a "trausconjugation" phenomenon occurs, in which the DNP group, after splitting off from its amino acid carrier, would attach covalenfly to an autologous protein carrier in the same way that DNFB forms conjugates with autologous proteins in vivo. The covalent bond between the DNP group and amino acids is classically considered to be quite stable, as testified by the wide use of dinltrophenylation for structural analysis of proteins. Splitting of the DNP-amino acid bond would usually be considered as leading to the formation of dinitrophenol or dinltroaniline, which was found to be nonlmmunogenic in our system. However, the possibility that our results with some consistently immunogenlc DNP-amino acids could have been due to transconjugation gained some credibility from the observation that extensive cross-reactions occur between DNCB and these DNP-amino acids. Furthermore, we have shown that antibodies induced by di-DNP-L-histidine have a definite specificity for the e-DNP-lysyl determinant. If transconjugation indeed occurs, one would expect the new conjugates formed in vivo to possess mostly e-DNP-lysyl specificity, as is the case for antibodies induced in vivo by DNCB or DNFB.
Some direct chemical evidence for transconjugation was reported recently by Shaltiel (25) , who demonstrated that S-DNP-cysteine, O-DNP-tyrosine, and N-DNP-histidine readily react under mild conditions with sulfhydryl reagents such as 2-mercaptoethanol to yield a DNP-mercapto derivative and the original amino acid. In this connection, it is striking to note that DNP-amino acids in which the DNP group is bound to a sulfur or an oxygen atom, or to a tertiary amine function, are precisely those which are most strongly and consistently /mmunogenic ( Table I ), and that a compound like DNP-l-pipetidine carbodithioate, in which the DNP group is bound to a non-~mluo acid cartier through a sulfur atom, is also immunogenic. Finally, it appears from our dose-response curves that compounds such as S-DNP-L-cysteine, O-DNP-L-tyrosine, or di-DNP-L-cystine are even more immunogenic than some DNP compounds definitely able to conjugate in vivo, e.g. dinitrobenzenesul/onic acid. Further evidence compatible with a transconjugation hypothesis is also obtained from our experiment in which an immunogenic DNP conjugate was apparently formed in vitro upon incubation of di-DNP-L-histidine with BGG. Although this result does not constitute final evidence that transconjugation took place, mere adsorption appears unlikely to account for the immunogenic effect. The control experiment in which BGG was not incubated, but merely mixed with di-DNP-T.-histidine prior to chromatographic separation, was negative.
We are therefore of the opinion that in the case of irregularly immunogeuic DNP-amlno acids we are certainly dealing with immunogeuic impurities, whereas a transconjugation phenomenon may well account for the imrnunogenicity of several regularly immunogenic DNP-~rnlno acids.
Accordingly, the possibility that the hapten-amlno acid molecule as s~h could exert its immunogenic effect on the antigen-sensitive cell appears rather remote. The reports postulating {mruunogenicity of a few hapten-~mluo acids (e.g. DNP-amlno adds, i~-azobenzene arsonate-tyrosine) are to be balanced with numerous negative observations. As our experience shows, usually accepted criteria of chromatographic purity are insufficient to ascertain that the compound designed as {mmunogenic is really responsible for the sensitization observed. Accordingly, we feel that the evidence presented by some other groups pointing to the immunogenicity of hapten-amino acids (5, 7, 8) has to be reevaluated, as in several instances the doses used for immunization, especially when incorporated in complete Freund's adjuvant, were sufficient on the basis of our experience with DNP-amino acids to attribute the results to some highly immunogenic impurity. In experiments dealing with the imrnunogenicity of hapten-~mluo acids, a systematic use of dose-response curves appears to be required, and control experiments involving incubation of the alleged compound with proteins in vitro should be followed by immunization with such proteins in order to exclude that significant conjugation or "transconjugation" has taken place.
SlY~r~d~Y
Numerous dinltrophenyl amino acid preparations injected intradermally induced contact hypersensitivity to dinltrochlorobenzene, delayed type skin reactions to DNP-amlno acids, and anti-DNP antibodies in guinea pigs. Some DNP-~mh~o acids induced precipitating anti-DNP antibodies in rabbits as well.
Some of the DNP-amino acids studied were regularly immunogenic, possible immunogenic impurities having been excluded by extensive purification procedures. Others were either constantly nonimmunogenic or irregularly immunogenic, e.g., their immunogenicity varying from one preparation lot to another.
By means of extensive chemical analyses and the establishment of doseresponse curves, we were able to demonstrate in most cases that the immunogenicity was not due to contamination with unreacted dinitrofluorobenzene or other DNP derivatives, to photodecomposition or other degradation products, or to DNP-protein contaminants. Nevertheless, the irregular immunogenicity of several DNP-amino acid preparations can only be explained by a highly immunogenic impurity (or impurities) which we were unable to detect analytically.
The regular immunogenicity of some other DNP-amlno acids (e.g. di-DNP-L-histidine) appears to be based on a "transconjugation" phenomenon, the DNP group being able to split off from its amino acid carrier and to conjugate secondarily with proteins in vivo and in vitro. Accordingly, the interpretation of some recent data concerning the immunogenicity of low molecular weight hapten-amino acids may have to be reevaluated.
